Showing results (901-910 of 970) with videos related to
Sort By:
Pageof 97
Pathogens and Disease|January 29, 2021
How can we interpret SARS-CoV-2 antibody test results?Sofie Føns, Karen A KrogfeltPathogens and Disease|January 29, 2021
Biobank for multidrug-resistant tuberculosis research: importance of sequential samplesYoohyun Hwang, Jiyeon Kim, Seungkyu Park, et al.Pathogens and Disease|February 2, 2021
Comparative study of sodium bicarbonate- and magnesium hydroxide-based gastric antacids for the effectiveness of Salmonella delivered Brucella antigens against wild type challenge in BALB/c miceChamith Hewawaduge, Amal Senevirathne, Myeon-Sik Yang, et al.Pathogens and Disease|January 20, 2021
SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the hostChristy Lite, Shiek S S J Ahmed, Melita Juliet, et al.Pathogens and Disease|October 5, 2019
Non-pigmented rapidly growing mycobacteria smooth and rough colony phenotypes pathogenicity evaluated using in vitro and experimental modelsMarta García-Coca, John-Jairo Aguilera-Correa, Arancha Ibáñez-Apesteguía, et al.Pathogens and Disease|September 11, 2019
Association of human papillomavirus infection and inflammation in cervical cancerNima Hemmat, Hossein Bannazadeh BaghiPathogens and Disease|January 21, 2021
Microbiology's next top model: Galleria in the molecular ageHue Dinh, Lucie Semenec, Sheemal S Kumar, et al.Pathogens and Disease|November 5, 2016
Monitoring of dynamin during the Toxoplasma gondii cell cycleLucio Ayres Caldas, Leandro Lemgruber Soares, Sergio Henrique Seabra, et al.Pathogens and Disease|November 6, 2016
Antibody profiles induced by Trypanosoma cruzi in chagasic patients with previous or current exposure to mycobacteriaLuz Peverengo, Estefanía Prochetto, Luz Rodeles, et al.Pathogens and Disease|March 2, 2019
P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combinationKaroline Henriksen, Nanna Rørbo, Morten Levin Rybtke, et al.Pageof 97